Hospital

Researchers applied extracellular vesicles retrieved from human red blood cells to serve as natural carrier to deliver the anti-cancer antisense oligonucleotides to the tumor site.

LBL-034 could be best in class in treating individuals with multiple myeloma.

High COVID-19 hospital caseload strain led to increases in inpatient adverse events among patients both with and without SARS-CoV-2 infection.

Failing is not final, and it does not define what kind of pharmacist or resident a student can be.

If accepted, daratumumab would be the first approved treatment for smoldering multiple myeloma.

In the trial, lumateperone had a significantly longer time to relapse in patients treated compared to placebo.

Automation can enhance safety and efficiency and allow staff to concentrate on higher-value tasks as direct patient care roles expand.

Pharmacists should be aware of current discussions, attempted fixes, and expected length of drug shortages.

Brivudine is more effective in treating herpes zoster and does not increase the risk of adverse reactions.

The demanding nature of pharmacy programs often leaves little time for self-care, social activities, or hobbies, leading to an imbalance that can foster burnout.

Though both vaccines remain effective at preventing severe illness, Moderna’s mRNA-1273.222 vaccine was found to be significantly more effective among adults with underlying medical conditions.

The drug is being investigated for its potential to reduce fibrosis associated with muscular dystrophy that can cause scarring of the heart tissue.

The nomogram model demonstrated good predictive capabilities to assess progression risk to overt primary myelofibrosis.

The analysis also found that the intervention methods could improve patients’ physical, cognitive, and emotional functioning.

RSV vaccines were 80% effective in preventing hospitalization, ICU admission, and death among adults aged 60 years and older.

Efforts include a mandatory intravenous immunoglobulin ordering form, blood bank gatekeeping, and a stewardship committee to ensure optimized use.

Expanding operations to provide specialty infusions can provide benefits to both patients and oncology practices.

Opioid stewardship pharmacist Maureen Saphire, PharmD, BCGP, focuses on advocating for appropriate opioid access for patients with cancer and sickle cell disease, promoting safe opioid use, and supporting leadership and strategic planning as keys to successful opioid stewardship.

New technology and innovation may help turn the corner on antibiotic resistance.

Clesrovimab reduced RSV-associated hospitalizations and RSV-associated lower respiratory infection hospitalizations by more than 84% and 90% in preterm and full-term infants, respectively.

Increased bone marrow adiposity is associated with progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma.

Known to be a leading cause of mortality worldwide, cigarette smoke exposure can make the respiratory tract more susceptible to pneumococcal infection.

RBL is the first FDA-approved microbiota-based live biotherapeutic product for adults.

Patients with low-grade intermediate-risk non-muscle-invasive bladder cancer who achieved a complete response rate after 3 months of UGN-102 treatment had an 82.3% duration of response at 12 months.

Insomnia exhibits a dose-response relationship with AF recurrence, indicating that an increased number of insomnia symptoms is associated with heightened probability of AF recurrence.

Educating the public about the dangers of self-medication and the importance of finishing prescribed antibiotic courses plays a crucial role

Jeff Boyer, PharmD, BCPS, discusses his role in opioid stewardship at the Southern Arizona VA Healthcare System, highlighting his work in pain management coordination, interdisciplinary collaboration, patient and provider education, and data-driven strategies to support safe opioid use and address the opioid crisis.

The findings show robust connections between symptoms, with variations in depression scores directly or indirectly influence fatigue and other symptoms.

Less than 16% of high-risk lung cancer individuals have heard or discussed lung cancer screenings with a health care provider.

The novel therapy demonstrated safety and efficacy in a clinical trial.